Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1

Patrick C McHugh, Josephine A Wright, David R Brown

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF-1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.

LanguageEnglish
Pagese17354
JournalPLoS One
Volume6
Issue number2
DOIs
Publication statusPublished - 28 Feb 2011
Externally publishedYes

Fingerprint

beta-Synuclein
response elements
Response Elements
Transcription Factors
transcription factors
Metals
promoter regions
metals
alpha-Synuclein
Synucleins
binding sites
therapeutics
neurodegenerative diseases
disease course
Genetic Promoter Regions
reporter genes
bioinformatics
protein synthesis
Binding Sites
Nucleic Acid Regulatory Sequences

Cite this

@article{bc5af948d5054926978a4ef98d6672cf,
title = "Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1",
abstract = "The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF-1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.",
keywords = "5' Untranslated Regions/genetics, Binding Sites/genetics, Cells, Cultured, DNA-Binding Proteins/metabolism, Electrophoretic Mobility Shift Assay, Gene Expression Regulation/drug effects, Humans, Metals/pharmacology, Mutagenesis, Site-Directed, Promoter Regions, Genetic/drug effects, Protein Binding/physiology, Response Elements/drug effects, Transcription Factors/metabolism, Transcriptional Activation/drug effects, beta-Synuclein/genetics",
author = "McHugh, {Patrick C} and Wright, {Josephine A} and Brown, {David R}",
year = "2011",
month = "2",
day = "28",
doi = "10.1371/journal.pone.0017354",
language = "English",
volume = "6",
pages = "e17354",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1. / McHugh, Patrick C; Wright, Josephine A; Brown, David R.

In: PLoS One, Vol. 6, No. 2, 28.02.2011, p. e17354.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1

AU - McHugh, Patrick C

AU - Wright, Josephine A

AU - Brown, David R

PY - 2011/2/28

Y1 - 2011/2/28

N2 - The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF-1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.

AB - The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF-1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.

KW - 5' Untranslated Regions/genetics

KW - Binding Sites/genetics

KW - Cells, Cultured

KW - DNA-Binding Proteins/metabolism

KW - Electrophoretic Mobility Shift Assay

KW - Gene Expression Regulation/drug effects

KW - Humans

KW - Metals/pharmacology

KW - Mutagenesis, Site-Directed

KW - Promoter Regions, Genetic/drug effects

KW - Protein Binding/physiology

KW - Response Elements/drug effects

KW - Transcription Factors/metabolism

KW - Transcriptional Activation/drug effects

KW - beta-Synuclein/genetics

U2 - 10.1371/journal.pone.0017354

DO - 10.1371/journal.pone.0017354

M3 - Article

VL - 6

SP - e17354

JO - PLoS One

T2 - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

ER -